$3 Million National Grant to Fund Pancreatic Cancer Study

UC Davis Comprehensive Cancer Center has partnered with TargaGenix and Northeastern University to study PDAC. The academic-industry partnership will receive nearly $3 million over five years thanks to National Institutes of Health funding through its R01 grant program.